Please select an option below to help us tailor your newsletter to best suit your content interests!
🏆 20 West physicians have been named Castle Connolly Top Doctors 🏆 Castle Connolly’s Top Docs represent the ✨top 7%✨ of all U.S. practicing physicians! Selected through a rigorous process of peer nominations and thorough vetting by a physician-led research team, these doctors are truly top-notch healthcare providers. Their exceptional clinical care, specialty expertise, and… Read more »
An abstract created in partnership with Dr. Gregory Vidal and Dr. Andrea Curry of our West family about Addressing Breast Cancer Disparities has been officially accepted by San Antonio Breast Cancer Symposium Alongside Rabble Health and the Urban Health Education & Support Services, this team will present methods used to measurably address social determinants of… Read more »
Exciting Advances in Endocrine Therapies for Breast Cancer! 🌟 In a recent OncLive Peer Exchange, our very own Dr. Gregory Vidal shares a panel with Dr. Komal Jhaveri, Dr. Timothy Pluard, Dr. Aditya Bardia, and Dr. VK Gadi to discuss the promising landscape of novel endocrine drugs. Discussion highlights include: – The emergence of selective… Read more »
This past weekend, Drs. Bradley Somer, Gregory Vidal, and Jason Porter hosted presentations at the Best of ASCO – Memphis Conference! This Post ASCO review showcased abstracts from highly rated presentations and the latest research in oncology education. Our physicians helped lead several discussions including: Dr. Jason Porter: – “Personalizing Treatment for Adult Patients with… Read more »
In a recent OncLive Peer Exchange, Dr. Gregory Vidal partnered with a panel of breast oncology experts to discuss the standard-of-care treatment approaches for early-stage HR-positive/HER2-negative breast cancer. Topics include: – Evolution of HER2-negative management – Updates in HR-positive treatment – Importance of genetic testing – Utilization of endocrine therapy – BRCA mutations and… Read more »
Through research and partnerships across the oncology community, we are committed to closing the gap in existing disparities in cancer care. A new study in partnership with Dr. Gregory Vidal and our West family, OneOncology, Genentech, and Flatiron Health examined elements of inequity in next generation sequencing (NGS) for patients with advanced non-small cell lung… Read more »
Here at West, we believe that diversity, equity, and inclusion are critical to reducing cancer disparities. On Friday, March 3, Dr. Gregory Vidal led a workshop called “Conversations for Change” aimed to encourage conversations about prevention, diagnosis, and treatment of cancer to primary care providers in our community. Discussions included: – Diagnostic Standards… Read more »
Diversity, equity, and inclusion are critical to reducing cancer disparities. We believe everyone should have the ability to benefit from advancements in the prevention, diagnosis, and treatment of cancer. West Medical Oncologist, Dr. Gregory Vidal, will be hosting a “Conversation for Change” on Friday, March 3 for Primary Care Providers to discuss: – Diagnostic Standards for… Read more »
“Women undergoing treatment for breast cancer require frequent clinic visits for maintenance of therapy. With COVID-19 causing health care disruptions, it is important to learn about how this population’s access to health care has changed.” The study linked below was co-authored by two of our very own – Dr. Gregory Vidal and Andrea Curry, and compares self-reported… Read more »